Spero Therapeutics, Inc. SPRO Q2 2026 earnings

FAQ

When did Spero Therapeutics, Inc. report Q2 2026 earnings?

Spero Therapeutics, Inc. (SPRO) reported Q2 2026 earnings on August 12, 2026 after market close.

What were Spero Therapeutics, Inc.'s Q2 2026 revenue and EPS?

Spero Therapeutics, Inc. reported eps of $-0.16 for Q2 2026.

Did Spero Therapeutics, Inc. beat estimates in Q2 2026?

EPS beat the consensus estimate of $-0.17 by $0.01.

How did Spero Therapeutics, Inc.'s Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps declined 433.3% from $-0.03.

Where can I find Spero Therapeutics, Inc.'s Q2 2026 SEC filings?

You can read the 8-K earnings release (0001193125-26-346855) and the 10-Q periodic report (0001193125-26-346795) directly on SEC EDGAR. The filing index links above go to sec.gov.